What is the price-to-earnings ratio of Affimed?
The price-earnings ratio of Affimed is currently -1.78.
Affimed P/E 2024
Affimed P/E
-1.78
Ticker
AFMD
ISIN
NL0010872420
WKN
A12BHU
As of Dec 18, 2024, Affimed's P/E ratio was -1.78, a 61.82% change from the -1.1 P/E ratio recorded in the previous year.
The Affimed P/E history
Affimed Aktienanalyse
What does Affimed do?
Affimed NV is a company specializing in the research, development, and marketing of immunotherapies for various types of cancer. The company was founded in 2000 and is headquartered in Heidelberg, Germany. It has been listed on the NASDAQ since 2014. Affimed focuses on developing innovative immunotherapies that adapt the body's immune defense mechanisms. The goal is to stimulate the body's defense against cancer cells. The company divides its work into three areas, reflected in its product range: 1. NK cell engager platform (NKG2D and CD16A engagers) 2. T cell engager platform (tandem fusions and bi- and tri-specifics) 3. ACCEL platform® (antibody-cell conjugates, enhanced loading) Affimed specializes in developing medicines for specific types of cancer with high medical needs, such as certain forms of lymphomas and solid tumors. The company collaborates with other companies to jointly develop and market medications. Its business model is based on partnerships to finance the development and commercialization of medications. In summary, Affimed NV specializes in the development of targeted immunotherapies for combating cancer cells. Its products specifically target NK cells and T cells and aim to promote an effective immune response against certain types of cancer. The company collaborates with other companies to advance therapy development and bring them to market. Affimed NV specializes in the development of immunotherapies for targeted treatment of cancer cells. Affimed ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Affimed's P/E Ratio
The Price to Earnings (P/E) Ratio of Affimed is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Affimed's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Affimed is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Affimed’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Affimed stock
How has the price-earnings ratio of Affimed changed compared to last year?
The price-to-earnings ratio of Affimed has increased by 61.82% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Affimed high compared to other companies?
Yes, the price-to-earnings ratio of Affimed is high compared to other companies.
How does an increase in the price-earnings ratio of Affimed affect the company?
An increase in the price-earnings ratio of Affimed would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Affimed affect the company?
A decrease in the price-earnings ratio of Affimed would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Affimed?
Some factors that influence the price-earnings ratio of Affimed are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Affimed pay?
Over the past 12 months, Affimed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Affimed is expected to pay a dividend of 0 EUR.
What is the dividend yield of Affimed?
The current dividend yield of Affimed is .
When does Affimed pay dividends?
Affimed pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Affimed?
Affimed paid dividends every year for the past 0 years.
What is the dividend of Affimed?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Affimed located?
Affimed is assigned to the 'Health' sector.
Wann musste ich die Aktien von Affimed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Affimed from 12/18/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.
When did Affimed pay the last dividend?
The last dividend was paid out on 12/18/2024.
What was the dividend of Affimed in the year 2023?
In the year 2023, Affimed distributed 0 EUR as dividends.
In which currency does Affimed pay out the dividend?
The dividends of Affimed are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Affimed stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Affimed
Our stock analysis for Affimed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Affimed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
